The global healthcare data monetization market is undergoing a major transformation as digitalization accelerates, real-world data gains strategic importance, and healthcare stakeholders increasingly pursue data-driven decision-making. Valued at USD 0.58 billion in 2025, the market is projected to reach USD 1.16 billion by 2030, growing at a robust CAGR of 14.9%. The rising commercial significance of clinical, claims, genomic, and patient-generated data is driving healthcare organizations, payers, life sciences companies, and digital health firms to adopt scalable data monetization models.
The growth trajectory is further supported by the emergence of Data-as-a-Service (DaaS) frameworks, expanding cloud-native health data exchanges, and increasing use of AI-driven analytics. With the proliferation of connected health devices and remote monitoring technologies, healthcare is generating unprecedented volumes of structured and unstructured data—creating substantial opportunities for monetization, innovation, and improved clinical outcomes.
Rising Demand for Real-World Evidence (RWE) Drives Market Expansion
One of the most influential drivers of the healthcare data monetization market is the global shift toward value-based care and the escalating need for real-world evidence (RWE). As the healthcare ecosystem moves from fee-for-service to outcome-focused models, stakeholders increasingly rely on real-world data (RWD) to evaluate treatment effectiveness, reduce costs, and improve patient outcomes.
How RWE Accelerates Data Monetization
- Payers and Providers:
RWE supports outcome-based contracting, risk stratification, care pathway optimization, and population health analytics. - Pharmaceutical and Biotech Companies:
Real-world datasets complement clinical trials by providing insights into long-term safety, adherence patterns, drug performance, and comparative effectiveness. - Regulatory Agencies:
Health authorities worldwide are adopting RWE for post-market surveillance, label expansion, and regulatory submissions.
This demand has accelerated the monetization of diverse datasets—clinical, claims, genomic, behavioral, and patient-generated—through specialized data networks, aggregators, and analytics platforms.
Examples of Leading RWE Platforms Monetizing Healthcare Data
- IQVIA:
Integrates EHR and claims data from 100+ million patients to generate insights for life sciences, supporting drug development, competitive intelligence, and safety studies. - Tempus:
A precision medicine pioneer that monetizes its extensive de-identified clinical-genomic database to offer AI-powered analytics for drug discovery and clinical trial optimization. - TriNetX:
Connects 200+ healthcare organizations globally, enabling feasibility studies, protocol simulations, patient stratification, and RWE analytics for biopharma.
These platforms reflect a rapidly expanding data ecosystem where health information is valued not just for clinical care but as a strategic asset driving innovation, revenue growth, and competitive advantage.
Key Factors Fueling Healthcare Data Monetization Adoption
Beyond RWE, several broader market forces are accelerating adoption:
- Digitalization of Healthcare Ecosystems
The global expansion of EHRs, telehealth platforms, wearables, and remote monitoring devices has resulted in exponential data growth. Healthcare organizations are increasingly exploring monetization models to leverage these high-value datasets.
- Demand for Actionable Insights
Healthcare providers, payers, and life sciences firms require real-time insights to:
- Improve patient outcomes
- Enhance operational efficiency
- Streamline workflows
- Predict disease risks
- Optimize clinical and commercial strategies
This demand fuels investments in analytics, AI, ML, and interoperability tools.
- Need for Alternative Revenue Streams
Declining reimbursements and rising operational costs are pushing providers and payers to create new revenue channels through:
- Data exchange
- Licensing agreements
- Collaborative DaaS partnerships
- Analytics-driven service expansion
- Growth of Connected Health and Consumer Data
Digital therapeutics, wellness apps, wearables, and IoT-enabled devices generate actionable real-time patient data—expanding the market for consumer-level data monetization.
Market Segmentation Insights
Direct Data Monetization Dominates the Market
In 2024, direct data monetization accounted for the largest market share. This approach involves selling or licensing datasets or analytics products directly to third parties such as pharma companies, insurers, and research institutions.
Direct monetization includes:
- Licensing de-identified datasets
- Selling access to real-time data platforms
- Offering analytics subscriptions
- Developing predictive and AI-powered tools
The segment is divided into software and services, with software holding the largest share due to increasing adoption of:
- Data analytics platforms
- Advanced integration tools
- API-based interoperability solutions
- Secure data exchange frameworks
These platforms automate data processing, ensure regulatory compliance, and support high-volume data commercialization workflows.
Cloud Deployment to Grow at the Highest CAGR
Among deployment models—on-premise and cloud—the cloud segment is projected to grow at the fastest pace. This growth is driven by:
- Lower infrastructure costs
- Scalability for handling large datasets
- API-driven integrations
- AI and machine learning capabilities
- Seamless access to real-time analytics
- Enhanced data security and compliance
Notable Cloud Developments Influencing the Market
- Oracle (2024):
Launched a cloud-based next-generation EHR powered by AI to automate clinical workflows and improve data accessibility. - Salesforce (2025):
Introduced Agentforce for Health, an AI-based suite improving patient scheduling, care coordination, and operational efficiency.
These innovations showcase the growing reliance on cloud-native platforms to support data monetization and digital transformation in healthcare.
Regional Insights: North America Leads the Market
In 2024, North America held the largest share of the healthcare data monetization market. Factors contributing to regional dominance include:
- Widespread adoption of EHRs, telemedicine, and connected devices
- Strong regulatory frameworks such as the 21st Century Cures Act promoting interoperability
- Robust AI, cloud, and analytics infrastructure
- Significant R&D investments from tech giants and health IT companies
- Presence of leading players such as Oracle, Microsoft, IBM, Google, Salesforce, and advanced health data startups
North America’s highly developed ecosystem of payers, providers, life sciences companies, and technology firms positions the region as a global leader in healthcare data monetization.
Key Market Players
Several global companies are shaping the future of healthcare data monetization. Key players include:
- Oracle Corporation
- Microsoft Corporation
- Salesforce, Inc.
- SAS Institute
- SAP SE
- TIBCO Software
- Sisense
- Snowflake Inc.
- QlikTech
- HealthVerity
- Accenture
- Availity
- Domo
- Komodo Health
- ThoughtSpot
- Datavant
- Innovaccer
- Infosys
- H1
- Medable
These companies focus on cloud innovation, interoperability, data marketplaces, AI-based analytics, and secure data exchange frameworks.
Conclusion
The healthcare data monetization market is on a high-growth trajectory fueled by digital transformation, the need for real-world evidence, and increasing adoption of AI and cloud platforms. As healthcare stakeholders seek new revenue models and improved patient outcomes, data monetization is emerging as a strategic imperative. With rapid advancements in analytics, interoperability, and AI, the market will see significant expansion through 2030—unlocking new opportunities across the global healthcare ecosystem.